Bellevue Group’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.2M | Sell |
64,498
-8,583
| -12% | -$1.76M | 0.27% | 60 |
|
|
2025
Q4 | $18.7M | Sell |
73,081
-3,229
| -4% | -$847K | 0.35% | 52 |
|
|
2025
Q3 | $19.9M | Buy |
76,310
+27,186
| +55% | +$7.15M | 0.41% | 45 |
|
|
2025
Q2 | $12M | Buy |
49,124
+20,826
| +74% | +$5.19M | 0.26% | 60 |
|
|
2025
Q1 | $7.49M | Sell |
28,298
-69
| -0.2% | -$18.7K | 0.17% | 78 |
|
|
2024
Q4 | $7.2M | Sell |
28,367
-73
| -0.3% | -$19.6K | 0.14% | 87 |
|
|
2024
Q3 | $9.01M | Hold |
28,440
| – | – | 0.15% | 86 |
|
|
2024
Q2 | $10.6M | Sell |
28,440
-107,101
| -79% | -$36.2M | 0.17% | 87 |
|
|
2024
Q1 | $47M | Buy |
135,541
+35,069
| +35% | +$13.3M | 0.72% | 42 |
|
|
2023
Q4 | $46M | Sell |
100,472
-69,574
| -41% | -$34.3M | 0.7% | 46 |
|
|
2023
Q3 | $82.7M | Buy |
170,046
+42,673
| +34% | +$20.1M | 1.33% | 18 |
|
|
2023
Q2 | $57M | Buy |
127,373
+58,803
| +86% | +$29.6M | 0.81% | 37 |
|
|
2023
Q1 | $33.3M | Sell |
68,570
-41,969
| -38% | -$20.7M | 0.48% | 60 |
|
|
2022
Q4 | $56.6M | Sell |
110,539
-23,667
| -18% | -$12.4M | 0.75% | 42 |
|
|
2022
Q3 | $65.1M | Sell |
134,206
-11,103
| -8% | -$5.4M | 0.93% | 38 |
|
|
2022
Q2 | $68M | Sell |
145,309
-2,133
| -1% | -$949K | 0.96% | 35 |
|
|
2022
Q1 | $64.2M | Sell |
147,442
-156,255
| -51% | -$65.4M | 0.75% | 46 |
|
|
2021
Q4 | $141M | Sell |
303,697
-9,065
| -3% | -$4.01M | 1.45% | 18 |
|
|
2021
Q3 | $122M | Buy |
312,762
+30,007
| +11% | +$12.7M | 1.24% | 24 |
|
|
2021
Q2 | $125M | Sell |
282,755
-5,964
| -2% | -$2.61M | 1.22% | 22 |
|
|
2021
Q1 | $121M | Buy |
288,719
+51,652
| +22% | +$20.6M | 1.28% | 23 |
|
|
2020
Q4 | $97.3M | Sell |
237,067
-6,929
| -3% | -$2.88M | 1.11% | 28 |
|
|
2020
Q3 | $101M | Buy |
243,996
+8,356
| +4% | +$3.36M | 1.4% | 17 |
|
|
2020
Q2 | $91.4M | Buy |
235,640
+37,522
| +19% | +$14M | 1.29% | 19 |
|
|
2020
Q1 | $62.2M | Sell |
198,118
-29,329
| -13% | -$9.89M | 1.21% | 20 |
|
|
2019
Q4 | $83.4M | Sell |
227,447
-15,226
| -6% | -$4.83M | 1.32% | 21 |
|
|
2019
Q3 | $62M | Buy |
242,673
+1,461
| +0.6% | +$410K | 1.15% | 25 |
|
|
2019
Q2 | $64M | Buy |
241,212
+88,735
| +58% | +$22.5M | 1.09% | 28 |
|
|
2019
Q1 | $40.6M | Buy |
152,477
+73,817
| +94% | +$21.3M | 2.23% | 10 |
|
|
2018
Q4 | $22.5M | Sell |
78,660
-19,850
| -20% | -$6.29M | 1.48% | 19 |
|
|
2018
Q3 | $33.3M | Buy |
98,510
+11,660
| +13% | +$3.79M | 2.12% | 13 |
|
|
2018
Q2 | $25.8M | Buy |
86,850
+3,150
| +4% | +$922K | 2.2% | 12 |
|
|
2018
Q1 | $22.5M | Buy |
83,700
+50,350
| +151% | +$13.6M | 2.23% | 12 |
|
|
2017
Q4 | $8.27M | Buy |
33,350
+2,000
| +6% | +$494K | 0.86% | 45 |
|
|
2017
Q3 | $7.64M | Buy |
31,350
+4,850
| +18% | +$1.19M | 0.8% | 44 |
|
|
2017
Q2 | $6.38M | Buy |
26,500
+7,500
| +39% | +$1.7M | 0.75% | 49 |
|
|
2017
Q1 | $3.92M | Buy |
19,000
+3,500
| +23% | +$724K | 0.52% | 57 |
|
|
2016
Q4 | $3.16M | Buy |
15,500
+4,700
| +44% | +$896K | 0.65% | 44 |
|
|
2016
Q3 | $1.91M | Sell |
10,800
-19,200
| -64% | -$3.33M | 0.35% | 78 |
|
|
2016
Q2 | $5.4M | Hold |
30,000
| – | – | 1.02% | 35 |
|
|
2016
Q1 | $5.49M | Buy |
+30,000
| New | +$5.2M | 1% | 33 |
|
Other funds holding HUM
VCM
VPM
SC
Bellevue Group's HUM Position: Q1 2026 in Review
Bellevue Group reduced its Humana (HUM) stake by 12% in Q1 2026, selling an estimated $1.76M and leaving 64,498 shares worth $11.2M. The position accounts for 0.27% of the portfolio, ranked #60.
Bellevue Group first reported a position in HUM in Q1 2016 and has held it in 41 quarters since. The position peaked at $141M in Q4 2021. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.
- Bellevue Group held 64,498 shares of Humana worth $11.2M as of Q1 2026.
- Bellevue Group sold 8,583 Humana shares in Q1 2026, an estimated $1.76M.
- Humana made up 0.27% of Bellevue Group's portfolio in Q1 2026, its #60 holding.
- Bellevue Group first reported a position in Humana in Q1 2016 and has held it in 41 quarters since.
- Bellevue Group's Humana position peaked at $141M in Q4 2021.
- 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.
Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.